부산대학교 도서관

Stirling, R.G.; Samankula, U.; Lloyd, M.; Brand, M.; Briggs, L.; Lesage, J.; Wood, T.; Underhill, C.; Parakh, S.; Faisal, W.; Blum, R.; Richardson, G.; Parente, P.; Caldecott, M.; Olesen, I.; Torres, J.; Samuel, E.; Jennings, B.; See, K.; Langton, D.; John, T.; Antippa, P.; Wright, G.M.; Conron, M.; Bartlett, J.; Harden, S.V.; Zalcberg, J.

Clinical Oncology. 44

E. Samuel; C. Thomas; C. Thompson; E. Paul; M. Cherk; S. Ellis; M. Siemienowicz; S. Tissera; U. Samankula; S. Scholz; L. Zhang; J. Grewal; J. Cox; C. Yu; G. Adabi; D. Keating; J. Taverner; J. Gooi; S. Wayne; J. Zalcberg; R. G. Stirling

Thoracic Cancer, Vol 16, Iss 11, Pp n/a-n/a (2025)

S. M. Evans; K. Ivanova; R. Rome; D. Cossio; CHC Pilgrim; J. Zalcberg; Y. Antill; L. Blake; A. Du Guesclin; A. Garrett; D. Giffard; N. Golobic; D. Moir; S. Parikh; A. Parisi; K. Sanday; C. Shadbolt; M. Smith; L. Te Marvelde; K. Williams

BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)

Casali P. G.; Le Cesne A.; Velasco A. P.; Kotasek D.; Rutkowski P.; Hohenberger P.; Fumagalli E.; Judson I. R.; Italiano A.; Gelderblom H.; Penel N.; Hartmann J. T.; Duffaud F.; Goldstein D.; Martin-Broto J.; Gronchi A.; Wardelmann E.; Marreaud S.; Zalcberg J. R.; Litiere S.; Blay J. -Y.

RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
instname

James C Lee; Liane J Ioannou; Jonathan Serpell; Julie A Miller; Brooke Nickel; John R Zalcberg; Benjamin Brown; Jeremy Millar; Rachael H Dodd; Anthony Glover; Bianka D'souza; Claire Bavor

BMJ Open, Vol 14, Iss 4 (2024)

Orchard SG; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Polekhina G; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Zalcberg J; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Bernstein W; Department of Medical Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland.; Uniformed Services University of Health Sciences, Bethesda, Maryland.; Macrae F; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Tie J; Personalised Oncology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Gately L; Personalised Oncology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, Victoria, Australia.; Department of Medical Oncology, Alfred Health, Melbourne, Victoria, Australia.; Mar V; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Millar J; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Department of Radiation Oncology, Alfred Health, Melbourne, Victoria, Australia.; Rodriguez LM; National Cancer Institute, Division of Cancer Prevention, Bethesda, Maryland.; Department of Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland.; van Londen GJ; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Kent A; Department of Radiation Oncology, Alfred Health, Melbourne, Victoria, Australia.; Hiscutt E; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Victorian Melanoma Service, Alfred Health, Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.; Ong WL; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Department of Radiation Oncology, Alfred Health, Melbourne, Victoria, Australia.; Warner ET; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.; Ford L; National Cancer Institute, Division of Cancer Prevention, Bethesda, Maryland.; Umar A; National Cancer Institute, Division of Cancer Prevention, Bethesda, Maryland.; McNeil JJ; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Nelson M; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Stocks N; Discipline of General Practice, University of Adelaide, Adelaide SA, Australia.; Shah RC; Department of Family & Preventive Medicine and the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.; Kirpach B; Berman Centre for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Division of Geriatrics, Department of Medicine Hennepin HealthCare, Minneapolis, Minnesota.; Murray A; Berman Centre for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Division of Geriatrics, Department of Medicine Hennepin HealthCare, Minneapolis, Minnesota.; University of Minnesota, Minneapolis.; Woods RL; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Ryan J; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Wolfe R; School of Public Health and Preventive Medicine, Monash University, Melbourne Victoria, Australia.; Gibbs P; Personalised Oncology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.; Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Naidoo M; School of Public Health Faculty of Medicine, Monash University, Melbourne, Australia.; Monash Health, Bentleigh East, Australia.; McNally O; University of Melbourne, Parkville, Australia.; Scott CL; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Peter MacCallum Cancer Centre, Melbourne, Australia.; Friedlander M; UNSW Sydney, Faculty of Medicine and Health, School of Clinical Medicine, Sydney, Australia.; Prince of Wales and Royal Hospital for Women, Sydney, Australia.; Cohen PA; University of Western Australia, Crawley, Australia.; King Edward Memorial Hospital, Perth, Australia.; Perera S; School of Public Health Faculty of Medicine, Monash University, Melbourne, Australia.; Lloyd M; School of Public Health Faculty of Medicine, Monash University, Melbourne, Australia.; Brand A; University of Sydney, Sydney, Australia.; Westmead Hospital, Sydney, Australia.; Richardson G; Cabrini Health, Malvern, Australia.; Bunting M; Royal Hobart Hospital, Hobart, Australia.; Mohan R; St John of God Healthcare, Gynaecology Oncology, West Leederville, Australia.; Oehler M; Royal Adelaide Hospital, Gynaecological Oncology, Adelaide, Australia.; University of Adelaide, Adelaide, Australia.; Hyde S; University of Melbourne, Parkville, Australia.; Mercy Hospital for Women, Melbourne, Australia.; Jobling T; Monash Health, Bentleigh East, Australia.; Farrell R; Chris O'Brien Lifehouse, Gynae-Oncology, Camperdown, Australia.; Rome R; Epworth HealthCare, East Melbourne, Australia.; Zalcberg J; School of Public Health Faculty of Medicine, Monash University, Melbourne, Australia.; Dept Medical Oncology, Alfred Health, Melbourne, Australia.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Sarsha Yap; Emily He; Sam Egger; David E Goldsbury; Jie-Bin Lew; Preston J Ngo; Joachim Worthington; Hannah Rillstone; John R Zalcberg; Jeff Cuff; Robyn L Ward; Karen Canfell; Eleonora Feletto; Julia Steinberg

BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)

Ashika D. Maharaj; John Lubel; Eileen Lam; Paul J. Clark; Oliver Duncan; Jacob George; Gary P. Jeffrey; Lara Lipton; Howard Liu; Geoffrey McCaughan; Eu‐Ling Neo; Jennifer Philip; Simone I. Strasser; Katherine Stuart; Alexander Thompson; Jonathan Tibballs; Thomas Tu; Michael C. Wallace; Alan Wigg; Marnie Wood; Amany Zekry; Elysia Greenhill; Liane J. Ioannou; Golo Ahlenstiel; Kaye Bowers; Stephen J. Clarke; Anouk Dev; Michael Fink; Mark Goodwin; Christos S. Karapetis; Miriam T. Levy; Kate Muller; James O'Beirne; David Pryor; James Seow; Nicholas Shackel; Caroline Tallis; Nick Butler; John K. Olynyk; Kate Reed‐Cox; John R. Zalcberg; Stuart K. Roberts

Hepatology Communications, Vol 6, Iss 11, Pp 3260-3271 (2022)

R. Mercieca-Bebber; E. H. Barnes; K. Wilson; Z. Samoon; E. Walpole; T. Mai; S. Ackland; M. Burge; G. Dickie; D. Watson; J. Leung; T. Wang; R. Bohmer; D. Cameron; J. Simes; V. Gebski; M. Smithers; J. Thomas; J. Zalcberg; A. P. Barbour

BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)

Vianna, Danielle Tavares; Reis Monte-Mór, Barbara da Costa; Noronha, Elda Pereira; Gutiyama, Luciana Mayumi; da Costa, Elaine Sobral; Pombo-de-Oliveira, Maria S; Zalcberg, Ilana

Leukemia Research. 143

Demetri, G.D. ; Antonescu, C.R. ; Bjerkehagen, B. ; Bovée, J.V.M.G. ; Boye, K. ; Chacón, M. ; Dei Tos, A.P. ; Desai, J. ; Fletcher, J.A. ; Gelderblom, H. ; George, S. ; Gronchi, A. ; Haas, R.L. ; Hindi, N. ; Hohenberger, P. ; Joensuu, H. ; Jones, R.L. ; Judson, I. ; Kang, Y.-K. ; Kawai, A. ; Lazar, A.J. ; Le Cesne, A. ; Maestro, R. ; Maki, R.G. ; Martín, J. ; Patel, S. ; Penault-Llorca, F. ; Premanand Raut, C. ; Rutkowski, P. ; Safwat, A. ; Sbaraglia, M. ; Schaefer, I.-M. ; Shen, L. ; Serrano, C. ; Schöffski, P. ; Stacchiotti, S. ; Sundby Hall, K. ; Tap, W.D. ; Thomas, D.M. ; Trent, J. ; Valverde, C. ; van der Graaf, W.T.A. ; von Mehren, M. ; Wagner, A. ; Wardelmann, E. ; Naito, Y. ; Zalcberg, J. ; Blay, J.-Y.

In Annals of Oncology November 2020 31(11):1506-1517

Neale RE; Population Health Program, QIMR Berghofer, Brisbane, Australia Rachel.Neale@qimrb.edu.au.; Jordan SJ; School of Public Health, The University of Queensland, Brisbane, Australia.; Thompson B; Population Health Program, QIMR Berghofer, Brisbane, Australia.; Bernardes CM; Population Health Program, QIMR Berghofer, Brisbane, Australia.; School of Public Health, The University of Queensland, Brisbane, Australia.; Adams J; Pancreatic Cancer Australia, Sydney, Australia.; Baggoley C; Pancreatic Cancer Australia, Sydney, Australia.; Barreto SG; Flinders University, South Australia, Australia.; Flinders Medical Centre, South Australia, Australia.; Baxter CM; Croagh D; Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.; St Vincent's Healthcare Association, Melbourne, Australia.; Devereaux B; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Royal Brisbane and Women's Hospital, Brisbane, Queensland.; Digestive Diseases Queensland, Brisbane, Australia.; Emery J; University of Melbourne, Melbourne, Australia.; Collins LG; School of Public Health, The University of Queensland, Brisbane, Australia.; Cancer Council Queensland, Brisbane, Australia.; Gilhotra R; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Royal Brisbane and Women's Hospital, Brisbane, Queensland.; Grogan P; University of Sydney, Sydney, Australia.; Hourigan L; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Princess Alexandra Hospital, Brisbane, Australia.; Martinez-Gutierrez J; University of Melbourne, Melbourne, Australia.; Pontificia Universidad Catolica de Chile, Santiago, Chile.; Metz AJ; Epworth Hospital, Melbourne, Australia.; Jreissati Pancreatic Centre, Melbourne, Australia.; Philcox S; John Hunter Hospital, Newcastle, Australia.; Rafiq M; University of Melbourne, Melbourne, Australia.; University College London, London, United Kingdom.; Rhee J; Discipline of General Practice, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Schrader S; University of Melbourne, Melbourne, Australia.; Stewart M; Pancreatic Cancer Australia, Sydney, Australia.; Windsor J; University of Auckland, Auckland, New Zealand.; Zalcberg J; Department of Medical Oncology, Alfred Health, Melbourne, Australia.; Research Program, Monash School of Public Health, Monash University, Melbourne, Australia.; Waterhouse M; Population Health Program, QIMR Berghofer, Brisbane, Australia.

Publisher: Royal College of General Practitioners Country of Publication: England NLM ID: 101713531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2398-3795 (Electronic) Linking ISSN: 23983795 NLM ISO Abbreviation: BJGP Open

O'Callaghan C; Caritas Christi and Department of Psychosocial Cancer Care (C.O.C.), St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia; Department of Medicine (C.O.C.), St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia.; Brooker J; Faculty of Psychology (J.B.), Counselling & Psychotherapy, The Cairnmillar Institute, Melbourne, Victoria, Australia.; Tissera S; School of Public Health and Preventive Medicine (S.T., D.S., J.Z., S.H.), Monash University, Melbourne, Victoria, Australia.; Samankula D; School of Public Health and Preventive Medicine (S.T., D.S., J.Z., S.H.), Monash University, Melbourne, Victoria, Australia.; Healy B; ACV/GARDS (B.H., K.H., V.H.), Moe, Victoria, Australia.; Healy K; ACV/GARDS (B.H., K.H., V.H.), Moe, Victoria, Australia.; Hamilton V; ACV/GARDS (B.H., K.H., V.H.), Moe, Victoria, Australia.; Philip J; St Vincent's Hospital Melbourne and The University of Melbourne (J.P.), Melbourne, Victoria, Australia.; Stirling R; Department of Respiratory Medicine (R.S.), Alfred Hospital, Melbourne, Victoria, Australia; Central Clinical School (R.S.), Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.; Zalcberg J; School of Public Health and Preventive Medicine (S.T., D.S., J.Z., S.H.), Monash University, Melbourne, Victoria, Australia; Medical Oncology Unit (J.Z.), Alfred Health, Melbourne, Victoria, Australia.; Schofield P; School of Computing (P.S.), Engineering and Mathematical Sciences, La Trobe University, Melbourne, Victoria, Australia; Department of Psychology (P.S.), and Iverson Health Innovation Research Institute Swinburne University, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology (P.S.), The University of Melbourne, Parkville, Victoria, Australia.; Harden S; School of Public Health and Preventive Medicine (S.T., D.S., J.Z., S.H.), Monash University, Melbourne, Victoria, Australia; Peter MacCallum Cancer Centre (S.H.), Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology (S.H.), University of Melbourne, Melbourne, Victoria, Australia. Electronic address: susan.harden@monash.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 8605836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6513 (Electronic) Linking ISSN: 08853924 NLM ISO Abbreviation: J Pain Symptom Manage Subsets: MEDLINE

Tissera S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Billah B; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Karim MN; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Antippa P; Department of Cardiothoracic Surgery, The Royal Melbourne Hospital, Melbourne, Australia.; University of Melbourne Department of Surgery, The Royal Melbourne Hospital, Melbourne, Australia.; Blum R; Bendigo Health Cancer Centre, Bendigo, Australia.; Caldecott M; Epworth Healthcare, Melbourne, Australia.; Conron M; Department of Respiratory and Sleep Medicine, St Vincent's Hospital, Melbourne, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.; Olesen I; Andrew Love Cancer Centre, Barwon Health, Geelong, Australia.; Deakin University, Geelong, Australia.; Parente P; Department Medical Oncology, Eastern Health, Melbourne, Australia.; Faculty of Medicine, Eastern Clinical School, Monash University, Melbourne, Australia.; Richardson G; Cabrini Health, Melbourne, Australia.; Samuel E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Medical Oncology, Latrobe Regional Health, Traralgon, Australia.; See K; Respiratory Medicine, Northern Health, Melbourne, Australia.; Underhill C; Border Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre, Albury, Australia.; Rural Medical School, University of New South Wales, Albury, New South Wales, Australia.; Wright G; Department of Cardiothoracic Surgery, St Vincent's Hospital, Melbourne, Australia.; University of Melbourne Department of Surgery, St Vincent's Hospital, Melbourne, Australia.; Torres J; Goulburn Valley Health, Shepparton, Australia.; Parakh S; Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Australia.; John T; Peter MacCallum Cancer Centre, Melbourne, Australia.; Zalcberg J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Medical Oncology, Alfred Health, Melbourne, Australia.; Faisal W; Department of Medical Oncology, Ballarat Regional Integrated Cancer Centre, Ballarat, Australia.; School of Health, La Trobe University, Melbourne, Australia.; Harden S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Stirling RG; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; School of Translational Medicine, Monash University, Melbourne, Australia.; Department of Respiratory Medicine, Alfred Health, Melbourne, Australia.

Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print Cited Medium: Internet ISSN: 1759-7714 (Electronic) Linking ISSN: 17597706 NLM ISO Abbreviation: Thorac Cancer Subsets: MEDLINE

McGauran M; Department of Gynaecological Oncology, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC 3084, Australia; Department of Obstetrics & Gynaecology, University of Melbourne, 163 Studley Rd, Heidelberg, VIC 3084, Australia. Electronic address: mmcgauran@mercy.com.au.; Hyde S; Department of Gynaecological Oncology, Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC 3084, Australia; Department of Obstetrics & Gynaecology, University of Melbourne, 163 Studley Rd, Heidelberg, VIC 3084, Australia.; Perera S; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia.; Lloyd M; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia.; Naidoo M; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia.; Sandhu S; Department of Obstetrics & Gynaecology, University of Melbourne, 163 Studley Rd, Heidelberg, VIC 3084, Australia; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia.; Knights T; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia.; Whitely A; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia.; Pritchard N; Department of Obstetrics & Gynaecology, University of Melbourne, 163 Studley Rd, Heidelberg, VIC 3084, Australia.; Zalcberg J; School of Public Health and Preventative Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC 3004, Australia; Alfred Health, 55 Commercial Rd, Melbourne, VIC 3004, Australia.; Rome R; Department of Obstetrics & Gynaecology, University of Melbourne, 163 Studley Rd, Heidelberg, VIC 3084, Australia.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Naidoo M; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University and Dept of Medical Oncology Alfred Health, Melbourne, VIC, Australia; Gynaecology Oncology, Epworth Hospital, Melbourne, VIC, Australia. Electronic address: Mahendra.naidoo@monash.edu.; Scott CL; Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Clinical Discovery Translation Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia.; McNally O; Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia; Obstetrics and Gynaecology, Royal Women's Hospital, Melbourne, VIC, Australia.; Rome R; Gynaecology Oncology, Epworth Hospital, Melbourne, VIC, Australia.; Perera S; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University and Dept of Medical Oncology Alfred Health, Melbourne, VIC, Australia.; Zalcberg J; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University and Dept of Medical Oncology Alfred Health, Melbourne, VIC, Australia; Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

Margalit O; Tel-Aviv University, Tel-Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel. Electronic address: Ofer.Margalit@sheba.health.gov.il.; Harmsen WS; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA.; Shacham-Shmueli E; Tel-Aviv University, Tel-Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel.; Voss MM; Department of Quantitative Science Research, Mayo Clinic, Scottsdale, AZ, USA.; Boursi B; Tel-Aviv University, Tel-Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel.; Wagner AD; Department of Oncology, Division of Medical Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Cohen R; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA; Sorbonne University, INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France.; Olswold CL; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA.; Saltz LB; Memorial Sloan Kettering Cancer Centre, New York, NY, USA.; Goldstein DA; Rabin Medical Centre, Petach Tikvah, Israel.; Hurwitz H; Duke Cancer Institute, Duke University, Durham, NC, USA.; Tebbutt NC; University of Melbourne, Melbourne, Australia; Austin Health, Heidelberg, Victoria, Australia.; Kabbinavar FF; David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA.; Adams RA; Cardiff University and Velindre Cancer Centre, Cardiff, UK.; Chibaudel B; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France.; Grothey A; West Cancer Center, Germantown, TN, USA.; Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Zalcberg J; Department of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, Australia.; de Gramont A; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France.; Shi Q; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA.; Lenz HJ; Department of Gastrointestinal Oncology, Keck School of Medicine at USC, Los Angeles, CA, USA.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE; PubMed not MEDLINE

Leong T; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Smithers BM; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Michael M; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Haustermans K; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Wong R; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Gebski V; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; O'Connell RL; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Zalcberg J; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Boussioutas A; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Findlay M; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Willis D; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Moore A; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Murray WK; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Lordick F; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; O'Callaghan C; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Swallow C; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Darling G; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Miller D; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Strickland A; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Liberman M; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Mineur L; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).; Simes J; From the Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne (T.L., M.M., W.K.M.), the School of Public Health, Monash University (J.Z.), the Department of Medical Oncology, Alfred Health (J.Z.), Central Clinical School, Alfred Centre (A.B.), and Monash Medical Centre (A.S.), Melbourne, VIC, Princess Alexandra Hospital, University of Queensland, Brisbane (B.M.S.), and Cancer Care Services, Sunshine Coast University Hospital, Birtinya, QLD (D.W.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney (V.G., R.L.O., J.S.), and Chris O'Brien Lifehouse (D.M.), Sydney, and the Trans-Tasman Radiation Oncology Group, University of Newcastle, Newcastle, NSW (A.M.) - all in Australia; the Department of Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium (K.H.); Princess Margaret Hospital (R.W.) and Mount Sinai Hospital (C.S.), Toronto, the Canadian Cancer Trials Group, Queen's University, Kingston, ON (C.O.), Nova Scotia Health Central Zone, Halifax (G.D.), and Centre Hospitalier de l'Université de Montréal, Montreal (M.L.) - all in Canada; the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (M.F.); University Cancer Center Leipzig and Comprehensive Cancer Center Central Germany Leipzig-Jena, University Medicine Leipzig, Leipzig, Germany (F.L.); and Sainte Catherine Institut du Cancer Avignon-Provence, Avignon, France (L.M.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Farbotko S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Owen A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Orchard SG; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Woods RL; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Nelson M; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Stocks NP; Discipline of General Practice, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.; Tonkin A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Wolfe R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; McNeil J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Gibbs P; The Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.; Zalcberg J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Ryan J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Publisher: published on behalf of ACOTA by Wiley-Blackwell Publishing Asia Country of Publication: Australia NLM ID: 9808874 Publication Model: Print Cited Medium: Internet ISSN: 1741-6612 (Electronic) Linking ISSN: 14406381 NLM ISO Abbreviation: Australas J Ageing Subsets: MEDLINE